Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

Out-of-Hospital Care
Corazon Offers Comprehensive Services to Ambulatory Surgery Centers, Including those Looking to Enter Cardiovascular
08/05/2024
“Our goal is to empower ASCs to enhance their cardiovascular services, ultimately improving patient outcomes and operational efficiency,” said Karen Hartman, President of Corazon. “With our comprehensive approach, we guide ASCs through the...
“Our goal is to empower ASCs to enhance their cardiovascular services, ultimately improving patient outcomes and operational efficiency,” said Karen Hartman, President of Corazon. “With our comprehensive approach, we guide ASCs through the...
“Our goal is to empower ASCs to...
08/05/2024
Cath Lab Digest
Scientists and clinicians at Scripps Research have shown that heart conditions can be diagnosed roughly as accurately using just three electrodes and an artificial intelligence (AI) tool. CREDIT Scripps Research
AI
New AI Tool Simplifies ECG: Fewer Leads, Same Accuracy
08/01/2024
Scientists report that their AI algorithm can recreate full 12-lead ECGs with data from only three ECG leads. Moreover, clinicians can identify heart attacks with nearly the same accuracy when they review the AI-generated ECGs as compared to...
Scientists report that their AI algorithm can recreate full 12-lead ECGs with data from only three ECG leads. Moreover, clinicians can identify heart attacks with nearly the same accuracy when they review the AI-generated ECGs as compared to...
Scientists report that their AI...
08/01/2024
Cath Lab Digest
Psychological Stress & HD
Stock Market Turbulence Linked to Increased Risk of Heart Attacks, Strokes, and Suicide: A Groundbreaking Study Analyzes 12 Million Deaths
08/01/2024
The research, which analyzed over 12 million deaths across China from 2013 to 2019, provides compelling evidence that the psychological stress induced by stock market fluctuations has severe and immediate health implications.
The research, which analyzed over 12 million deaths across China from 2013 to 2019, provides compelling evidence that the psychological stress induced by stock market fluctuations has severe and immediate health implications.
The research, which analyzed...
08/01/2024
Cath Lab Digest

Advertisement

Mental Health
AHA: Risks of Anxiety, Suicide Attempt May Rise Significantly After Cardiovascular Hospitalization
07/31/2024
This analysis of a large database included environmental and lifestyle factors that assessed both short- and long-term risk. It also reviewed whether different genetic susceptibilities to psychiatric disorders affect the possible link between...
This analysis of a large database included environmental and lifestyle factors that assessed both short- and long-term risk. It also reviewed whether different genetic susceptibilities to psychiatric disorders affect the possible link between...
This analysis of a large...
07/31/2024
Cath Lab Digest
Peripheral Interventions
VentureMed Completes Enrollment of the FLEX Vessel Prep System FLEX First AV Registry For The Treatment of Arteriovenous (AV) Access Management
07/30/2024
The FLEX Vessel Prep System has a unique non-balloon-based mechanism of action that creates longitudinal micro-incisions that release circumferential tension in diseased vessels. This release of tension is how FLEX modifies AV stenoses to...
The FLEX Vessel Prep System has a unique non-balloon-based mechanism of action that creates longitudinal micro-incisions that release circumferential tension in diseased vessels. This release of tension is how FLEX modifies AV stenoses to...
The FLEX Vessel Prep System has...
07/30/2024
Cath Lab Digest
Peripheral Interventions
Transit Scientific’s Novel XO Cath Microcatheter Breaks New Ground in Transradial Embolic Delivery Procedure
07/30/2024
​ Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, announced a milestone achievement with the successful utilization of XO Cath, its pioneering embolic delivery...
​ Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, announced a milestone achievement with the successful utilization of XO Cath, its pioneering embolic delivery...
​ Transit Scientific, a...
07/30/2024
Cath Lab Digest

Advertisement

Carotid Artery Revascularization
Silk Road Medical Celebrates Milestone of 100,000 Transcarotid Artery Revascularization (TCAR) Procedures
07/30/2024
Transcarotid Artery Revascularization (TCAR) is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a...
Transcarotid Artery Revascularization (TCAR) is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a...
Transcarotid Artery...
07/30/2024
Cath Lab Digest
Scoring Systems
New Score System Developed to Better Screen and Treat HFpEF Heart Failure Patients
07/29/2024
With the new, simple scoring system, “We are able to screen and effectively identify patients with a high probability of HFpEF at the population level,” says Varun Sundaram, MD, PhD, MSc, FRCP (UK). “We’re tapping into an opportunity to...
With the new, simple scoring system, “We are able to screen and effectively identify patients with a high probability of HFpEF at the population level,” says Varun Sundaram, MD, PhD, MSc, FRCP (UK). “We’re tapping into an opportunity to...
With the new, simple scoring...
07/29/2024
Cath Lab Digest
Health Care Needs
JACC: Almost Half of U.S. Counties Have No Cardiologists Despite Higher Prevalence of CV Risk Factors, Mortality
07/29/2024
Upon analyzing all 3,143 U.S. counties, it was determined that 1,454 counties (46.3%) with 22 million residents had no cardiologists while the other 1,689 counties each had 24 cardiologists on average. 86.2% of rural counties had no...
Upon analyzing all 3,143 U.S. counties, it was determined that 1,454 counties (46.3%) with 22 million residents had no cardiologists while the other 1,689 counties each had 24 cardiologists on average. 86.2% of rural counties had no...
Upon analyzing all 3,143 U.S....
07/29/2024
Cath Lab Digest

Advertisement

Acquisitions
Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix
07/26/2024
Edwards has entered into an agreement to acquire JenaValve Technology, a pioneer in the transcatheter treatment of aortic regurgitation (AR), and building on an investment made in 2016, Edwards has exercised its option to acquire Endotronix,...
Edwards has entered into an agreement to acquire JenaValve Technology, a pioneer in the transcatheter treatment of aortic regurgitation (AR), and building on an investment made in 2016, Edwards has exercised its option to acquire Endotronix,...
Edwards has entered into an...
07/26/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

News

DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest
acute mI
CLEAR SYNERGY (OASIS 9) Trial @TCT: Routine Colchicine Administration After Acute Myocardial Infarction Does Not Improve Outcomes
10/30/2024
Colchicine is an oral medication that reduces inflammation and smaller studies have indicated potential benefits for cardiovascular patients.
Colchicine is an oral medication that reduces inflammation and smaller studies have indicated potential benefits for cardiovascular patients.
Colchicine is an oral medication...
10/30/2024
Cath Lab Digest
Intravascular Lithotripsy
Data From Elixir’s PINNACLE I Trial for Calcium Fragmentation in Calcified Coronary Artery Lesions Presented at TCT
10/30/2024
An intravascular imaging sub-study using optical coherence tomography (OCT) was conducted to accurately assess lesion complexity and calcium fragmentation effectiveness of LithiX IVL across a range of complex calcium morphologies.
An intravascular imaging sub-study using optical coherence tomography (OCT) was conducted to accurately assess lesion complexity and calcium fragmentation effectiveness of LithiX IVL across a range of complex calcium morphologies.
An intravascular imaging...
10/30/2024
Cath Lab Digest
Tricuspid Valve Treatment
TCT: TRISCEND II Trial Demonstrates Superior Clinical and Quality-of-Life Benefits With Edwards Evoque System for Severe Tricuspid Regurgitation
10/30/2024
TRISCEND II is a randomized controlled pivotal trial designed to study the Evoque transcatheter tricuspid valve replacement (TTVR) system with optimal medical therapy (OMT) compared to OMT alone with 2:1 randomization.
TRISCEND II is a randomized controlled pivotal trial designed to study the Evoque transcatheter tricuspid valve replacement (TTVR) system with optimal medical therapy (OMT) compared to OMT alone with 2:1 randomization.
TRISCEND II is a randomized...
10/30/2024
Cath Lab Digest
Post MI
After a Heart Attack, the Heart Signals to the Brain to Increase Sleep to Promote Healing
10/30/2024
The novel findings, published in Nature, emphasize the importance of increased sleep after a heart attack, and suggest that sufficient sleep should be a focus of post-heart-attack clinical management and care, including in the intensive care...
The novel findings, published in Nature, emphasize the importance of increased sleep after a heart attack, and suggest that sufficient sleep should be a focus of post-heart-attack clinical management and care, including in the intensive care...
The novel findings, published in...
10/30/2024
Cath Lab Digest
Bioadaptors
TCT: DynamX Bioadaptor Demonstrates Significant Improvement Over Contemporary Drug-Eluting Stent in Patients with Acute Coronary Syndrome and Complex Lesion Subsets After Six Months
10/29/2024
Data demonstrate significant benefit of the DynamX® Coronary Bioadaptor System compared to a contemporary zotarolimus drug-eluting stent for target lesion failure in complex patient population subsets from the INFINITY-SWEDEHEART RCT.
Data demonstrate significant benefit of the DynamX® Coronary Bioadaptor System compared to a contemporary zotarolimus drug-eluting stent for target lesion failure in complex patient population subsets from the INFINITY-SWEDEHEART RCT.
Data demonstrate significant...
10/29/2024
Cath Lab Digest
Aortic Stenosis
TCT: Real-World Evidence Demonstrates Improved Survival in Asymptomatic Aortic Stenosis Patients Undergoing Aortic Valve Replacement (AVR)
10/29/2024
The study analyzed data from over 2 million patients in a real-world database of 29 teaching and non-teaching U.S. health systems.
The study analyzed data from over 2 million patients in a real-world database of 29 teaching and non-teaching U.S. health systems.
The study analyzed data from...
10/29/2024
Cath Lab Digest
Zilver Vena Stent
Zilver Vena Stent Shows High Patency Across All Patient Groups in Three-Year Clinical Study
10/29/2024
Bloomington, Ind. — Cook Medical’s Zilver Vena® Venous Self-Expanding Stent has shown high rates of patency sustained for three years, according to recently published data in the Journal of Vascular and Interventional Radiology (JVIR).1 The...
Bloomington, Ind. — Cook Medical’s Zilver Vena® Venous Self-Expanding Stent has shown high rates of patency sustained for three years, according to recently published data in the Journal of Vascular and Interventional Radiology (JVIR).1 The...
Bloomington, Ind. — Cook...
10/29/2024
Vascular Disease Management
Coronary Atherectomy
TCT: Treating Severe Calcification With an Atherectomy Device Does Not Improve Cardiac Stenting Outcomes, ECLIPSE Study Finds
10/29/2024
"The use of orbital atherectomy may be reserved for the most extreme cases for which the operator does not believe that balloon angioplasty would be likely to safely cross or pre-dilate the calcified lesion,” said Gregg Stone, MD.
"The use of orbital atherectomy may be reserved for the most extreme cases for which the operator does not believe that balloon angioplasty would be likely to safely cross or pre-dilate the calcified lesion,” said Gregg Stone, MD.
"The use of orbital atherectomy...
10/29/2024
Cath Lab Digest
Large Bore Closure
TCT: Vivasure Announces Positive Results of PATCH IDE Pivotal Study Indicating Safety and Efficacy of PerQseal Large Hole Closure Device
10/29/2024
The Vivasure PerQseal® Closure Device System (PerQSeal) is the first sutureless, fully absorbable synthetic implement for large-bore vessel punctures, and is an alternative to the use of suture- or collagen-based closure devices.
The Vivasure PerQseal® Closure Device System (PerQSeal) is the first sutureless, fully absorbable synthetic implement for large-bore vessel punctures, and is an alternative to the use of suture- or collagen-based closure devices.
The Vivasure PerQseal® Closure...
10/29/2024
Cath Lab Digest

Advertisement

Advertisement

TAVR
TAVR UNLOAD @TCT: Transcatheter Aortic Valve Replacement in Patients with Systolic Heart Failure and Moderate Aortic Stenosis Shows Limited Benefits
10/30/2024
Findings from the TAVR UNLOAD study found limited benefits of transcatheter aortic valve replacement (TAVR) in the treatment of heart failure (HF) with reduced ejection fraction (HFrEF) and moderate aortic stenosis (AS).
Findings from the TAVR UNLOAD study found limited benefits of transcatheter aortic valve replacement (TAVR) in the treatment of heart failure (HF) with reduced ejection fraction (HFrEF) and moderate aortic stenosis (AS).
Findings from the TAVR UNLOAD...
10/30/2024
Cath Lab Digest
DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest
acute mI
CLEAR SYNERGY (OASIS 9) Trial @TCT: Routine Colchicine Administration After Acute Myocardial Infarction Does Not Improve Outcomes
10/30/2024
Colchicine is an oral medication that reduces inflammation and smaller studies have indicated potential benefits for cardiovascular patients.
Colchicine is an oral medication that reduces inflammation and smaller studies have indicated potential benefits for cardiovascular patients.
Colchicine is an oral medication...
10/30/2024
Cath Lab Digest
Intravascular Lithotripsy
Data From Elixir’s PINNACLE I Trial for Calcium Fragmentation in Calcified Coronary Artery Lesions Presented at TCT
10/30/2024
An intravascular imaging sub-study using optical coherence tomography (OCT) was conducted to accurately assess lesion complexity and calcium fragmentation effectiveness of LithiX IVL across a range of complex calcium morphologies.
An intravascular imaging sub-study using optical coherence tomography (OCT) was conducted to accurately assess lesion complexity and calcium fragmentation effectiveness of LithiX IVL across a range of complex calcium morphologies.
An intravascular imaging...
10/30/2024
Cath Lab Digest
Tricuspid Valve Treatment
TCT: TRISCEND II Trial Demonstrates Superior Clinical and Quality-of-Life Benefits With Edwards Evoque System for Severe Tricuspid Regurgitation
10/30/2024
TRISCEND II is a randomized controlled pivotal trial designed to study the Evoque transcatheter tricuspid valve replacement (TTVR) system with optimal medical therapy (OMT) compared to OMT alone with 2:1 randomization.
TRISCEND II is a randomized controlled pivotal trial designed to study the Evoque transcatheter tricuspid valve replacement (TTVR) system with optimal medical therapy (OMT) compared to OMT alone with 2:1 randomization.
TRISCEND II is a randomized...
10/30/2024
Cath Lab Digest
Post MI
After a Heart Attack, the Heart Signals to the Brain to Increase Sleep to Promote Healing
10/30/2024
The novel findings, published in Nature, emphasize the importance of increased sleep after a heart attack, and suggest that sufficient sleep should be a focus of post-heart-attack clinical management and care, including in the intensive care...
The novel findings, published in Nature, emphasize the importance of increased sleep after a heart attack, and suggest that sufficient sleep should be a focus of post-heart-attack clinical management and care, including in the intensive care...
The novel findings, published in...
10/30/2024
Cath Lab Digest
Bioadaptors
TCT: DynamX Bioadaptor Demonstrates Significant Improvement Over Contemporary Drug-Eluting Stent in Patients with Acute Coronary Syndrome and Complex Lesion Subsets After Six Months
10/29/2024
Data demonstrate significant benefit of the DynamX® Coronary Bioadaptor System compared to a contemporary zotarolimus drug-eluting stent for target lesion failure in complex patient population subsets from the INFINITY-SWEDEHEART RCT.
Data demonstrate significant benefit of the DynamX® Coronary Bioadaptor System compared to a contemporary zotarolimus drug-eluting stent for target lesion failure in complex patient population subsets from the INFINITY-SWEDEHEART RCT.
Data demonstrate significant...
10/29/2024
Cath Lab Digest
Aortic Stenosis
TCT: Real-World Evidence Demonstrates Improved Survival in Asymptomatic Aortic Stenosis Patients Undergoing Aortic Valve Replacement (AVR)
10/29/2024
The study analyzed data from over 2 million patients in a real-world database of 29 teaching and non-teaching U.S. health systems.
The study analyzed data from over 2 million patients in a real-world database of 29 teaching and non-teaching U.S. health systems.
The study analyzed data from...
10/29/2024
Cath Lab Digest
Zilver Vena Stent
Zilver Vena Stent Shows High Patency Across All Patient Groups in Three-Year Clinical Study
10/29/2024
Bloomington, Ind. — Cook Medical’s Zilver Vena® Venous Self-Expanding Stent has shown high rates of patency sustained for three years, according to recently published data in the Journal of Vascular and Interventional Radiology (JVIR).1 The...
Bloomington, Ind. — Cook Medical’s Zilver Vena® Venous Self-Expanding Stent has shown high rates of patency sustained for three years, according to recently published data in the Journal of Vascular and Interventional Radiology (JVIR).1 The...
Bloomington, Ind. — Cook...
10/29/2024
Vascular Disease Management
Coronary Atherectomy
TCT: Treating Severe Calcification With an Atherectomy Device Does Not Improve Cardiac Stenting Outcomes, ECLIPSE Study Finds
10/29/2024
"The use of orbital atherectomy may be reserved for the most extreme cases for which the operator does not believe that balloon angioplasty would be likely to safely cross or pre-dilate the calcified lesion,” said Gregg Stone, MD.
"The use of orbital atherectomy may be reserved for the most extreme cases for which the operator does not believe that balloon angioplasty would be likely to safely cross or pre-dilate the calcified lesion,” said Gregg Stone, MD.
"The use of orbital atherectomy...
10/29/2024
Cath Lab Digest

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use